Why is Windlas Biotech falling/rising?

As of 06-Aug, Windlas Biotech Ltd is experiencing a decline in its stock price, currently at Rs 918.80, which reflects a decrease of Rs 35.3 or 3.7%. The stock has underperformed its sector by 1.49% today and has been on a downward trend for the last two days, accumulating a total loss of 7.13%. It reached an intraday low of Rs 912.05, indicating significant selling pressure. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. The stock's performance over the past week shows a decline of 7.60%, while it has gained 1.75% over the past month. Year-to-date, it is down 11.09%, contrasting with a 14.53% increase over the past year. Unfortunately, the positive and negative factors impacting the stock are not available.
Broader market context indicates that the pharmaceutical and drugs sector has also faced a decline, falling by 2.17%. In comparison to the Sensex, Windlas Biotech's short-term performance has been notably weaker, with a 1-week return of -7.60% against the benchmark's -1.15%. This underperformance highlights the stock's struggles in a challenging market environment, further compounded by a decrease in investor participation, as evidenced by a 7.48% drop in delivery volume compared to the 5-day average. Overall, the combination of sector-wide declines and specific stock challenges has contributed to Windlas Biotech's recent price drop.